Close Menu

NIH funding

The award will help fund development of the firm's "ksim" algorithm to determine infection relatedness in suspected hospital-acquired infection outbreaks.

The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.

The bill would increase funding for a number of NIH projects including the All of Us precision medicine initiative and the BRAIN initiative.

There are some deep divisions between the three main databases, some due to competitive pressures and others because of the nature of metabolomics.

The team said it will partner with startup Early Diagnostics to commercialize the assay, which integrates DNA methylation analysis and computational technology.

HudsonAlpha's Genome Gateway collects family histories and facilitates secure communication between patients, clinicians, and researchers.

A $5 million NIH grant will fund CPIC's ongoing work to develop PGx guidelines and an API for incorporating them into EHRs and clinical decision support systems.

The institutions will develop a cloud-based storage and compute infrastructure for unrestricted and controlled-access data and metadata from NHGRI's projects.

The National Institutes of Health Commercial Accelerator Program helps small healthcare and life science companies bring their products to market.

The funding will help the consortium continue creating and updating PGx guidelines, adding drug-gene pairings, and creating electronic tables that can be integrated within EHRs.

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.